Increasing Private Label Credit Card Transactions in Healthcare

Cutting Corners in China: Credit Cards Circumvent Cash Advance Controls and Limits

Cutting Corners in China: Credit Cards Circumvent Cash Advance Controls and Limits

Synchrony is a case study in doing a successful spin-off.  Performance has been steady since Synchrony departed from GE.  4Q17 investor reporting indicates 7% receivable growth, 8% net income increase, with rising, but under control writeoffs at 5.78%, up from 4.65% over prior year.

Synchrony operates three strategic business units, the retail card, with $56 billion in receivables; payment solutions, with $17 billion in receivables; and Care Credit, with $9 billion.

Today’s read comes from the Stamford Advocate, announcing that Care Credit is expanding its offerings to cover health spas, complementing the firm’s acceptance for elective health and beauty procedures.

Private label payments allow consumers to keep transactions outside of their bank cards.

What to watch for: will this push Care Credit from a 20% contributor of Synchrony’s receivable deeper into their portfolio?

…It could be a beautiful thing.

Overview by Brian Riley, Director, Credit Advisory Service at Mercator Advisory Group

Read the quoted story here

Exit mobile version